Tim Mayleben

Tim Mayleben

Director/Board Member at MARINUS PHARMACEUTICALS, INC.

Net worth: 24 815 $ as of 2024-04-29

63 year
Health Technology
Finance
Consumer Services

Network origin in Tim Mayleben first degree

EntityEntity typeIndustry
Kellogg School of Management
166
College/University Other Consumer Services 166
Public Company Pharmaceuticals: Major 47
Public Company Pharmaceuticals: Major 38
Public Company Pharmaceuticals: Major 28
Subsidiary Pharmaceuticals: Major 16
Public Company Biotechnology 15
10
Extinct Medical/Nursing Services 10
Stephen M. Ross School of Business
9
College/University Other Consumer Services 9
3
Venture Capital Fund Investment Managers 3
1
Private Company Investment Managers 1

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Tim Mayleben via their personal network

CompanySectorRelated peopleMain position
University of Michigan College/University

Ronald M. Cresswell

Gil Omenn

Frank Thomas

Mary L. Campbell

Scott Durbin

Ryan Waddington

Sharon M. Watling

Caryn Cramer-Babycz

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Undergraduate Degree

Corporate Officer/Principal

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

Doctorate Degree

PFIZER, INC. Pharmaceuticals: Major

Robert Zerbe

Tracy M. Woody

Christopher Michael Cashman

Narendra D. Lalwani

April L. Seiler

Santiago Arroyo

Fabio Cataldi

Chief Tech/Sci/R&D Officer

Sales & Marketing

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Biotechnology

David Bonita

Avi Z. Naider

Steven Elms

Josh Bilenker

Jennifer Burstein

Director/Board Member

Director/Board Member

Director/Board Member

Founder

Corporate Officer/Principal

College/University

Harold C. Urschel

Louis Lange

Stephen Bloch

David Bonita

Will Price

Doctorate Degree

Corporate Officer/Principal

Graduate Degree

Undergraduate Degree

Undergraduate Degree

Rochester Christian University College/University

Louis Lange

Nicole Vitullo

Carol Karp

Stephen Bloch

Sérgio Tavares Rebelo

Director/Board Member

Undergraduate Degree

Director/Board Member

Doctorate Degree

Doctorate Degree

ELI LILLY AND COMPANY Pharmaceuticals: Major

Nelson M. Sims

Robert Zerbe

Dominick Colangelo

Josh Bilenker

Corporate Officer/Principal

General Counsel

Corporate Officer/Principal

Corporate Officer/Principal

Michigan State University College/University

Brian D. Gibson

Shane McCarthy

Rick Bartram

Heidi Hassen

Undergraduate Degree

Undergraduate Degree

Graduate Degree

Undergraduate Degree

Investment Managers

Dov Goldstein

Scott Braunstein

Steven Elms

Josh Bilenker

Private Equity Investor

Private Equity Investor

Private Equity Investor

Private Equity Investor

Parke, Davis & Co. LLC

Ronald M. Cresswell

Robert Zerbe

Narendra D. Lalwani

April L. Seiler

Chairman

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

Yale University College/University

David I. Scheer

Elan Ezickson

Scott Durbin

Noah Yates

Corporate Officer/Principal

Undergraduate Degree

Graduate Degree

Undergraduate Degree

Pharmaceuticals: Major

Jay Shepard

Tracy M. Woody

Steven Elms

Anand Mehra

Chief Executive Officer

Sales & Marketing

Director/Board Member

Director/Board Member

Princeton University College/University

Harold C. Urschel

Gil Omenn

Mark E. McGovern

Josh Bilenker

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Investment Managers

Christopher Garabedian

Konstantin Poukalov

Frederick Callori

Private Equity Investor

Corporate Officer/Principal

Private Equity Investor

University of Maryland College/University

Christopher Garabedian

Christy Shafer

Dawn Louro

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

AMBIT BIOSCIENCES CORP Pharmaceuticals: Major

Alan Fuhrman

David Bonita

Steven Elms

Director of Finance/CFO

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Christopher Garabedian

Christopher Michael Cashman

Frederick Callori

Director/Board Member

Director/Board Member

Director/Board Member

Stanford University College/University

Dov Goldstein

Patrick Enright

Steven Elms

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Investment Managers

Gil Omenn

George Dunbar

Roger S. Newton

Corporate Officer/Principal

Private Equity Investor

Corporate Officer/Principal

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Mark E. McGovern

Adeoye Olukotun

Santiago Arroyo

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

ACHILLION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Nicole Vitullo

David I. Scheer

Martha Manning

Chairman

Chairman

General Counsel

MERCK & CO., INC. Pharmaceuticals: Major

Jeffrey Berkowitz

Sheldon Koenig

Marvin Johnson

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Harvard Medical School College/University

Gil Omenn

Louis Lange

Enrique Carrazana

Doctorate Degree

Doctorate Degree

Doctorate Degree

Pharmaceuticals: Major

Patrick Enright

Martha Manning

Gregory Oakes

Corporate Officer/Principal

General Counsel

Corporate Officer/Principal

H. LUNDBECK A/S Pharmaceuticals: Major

Jeffrey Berkowitz

Santiago Arroyo

Director/Board Member

Director/Board Member

Eastern Michigan University College/University

April L. Seiler

Tod Borton

Undergraduate Degree

Undergraduate Degree

Pharmaceuticals: Major

Nicole Vitullo

Michael S. Saporito

Investor Relations Contact

Corporate Officer/Principal

Pharmaceuticals: Major

Nicole Vitullo

Lori Kunkel

Director/Board Member

Corporate Officer/Principal

Investment Managers

Jay Shepard

Anand Mehra

Corporate Officer/Principal

Private Equity Investor

University of Mumbai College/University

Narendra D. Lalwani

Sara Nochur

Doctorate Degree

Graduate Degree

Pharmaceuticals: Major

John M. Krayacich

Gregory Oakes

Corporate Officer/Principal

Corporate Officer/Principal

RELYPSA INC Pharmaceuticals: Major

Jay Shepard

Gregory Oakes

Founder

Corporate Officer/Principal

University of Richmond College/University

R. Douglas Armstrong

Noah Yates

Undergraduate Degree

Masters Business Admin

Miscellaneous Commercial Services

Gil Omenn

Antonio M. Gotto

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Christopher Garabedian

Frederick Callori

Chief Executive Officer

Corporate Officer/Principal

Pharmaceuticals: Major

Christopher Garabedian

Frederick Callori

Director/Board Member

Director/Board Member

CELGENE Biotechnology

Christopher Garabedian

Gregory Oakes

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Christopher Garabedian

Frank Thomas

Director/Board Member

Director/Board Member

AMGEN INC. Pharmaceuticals: Major

Gil Omenn

Gregory Oakes

Director/Board Member

Corporate Officer/Principal

College/University

Gil Omenn

Louis Lange

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Gil Omenn

Antonio M. Gotto

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Gil Omenn

Louis Lange

Corporate Officer/Principal

Chairman

Clemson University College/University

Gregory Oakes

Steven Pfanstiel

Masters Business Admin

Graduate Degree

AEGERION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Antonio M. Gotto

David I. Scheer

Director/Board Member

Founder

Santa Clara University College/University

Jay Shepard

Michael Barrett

Director/Board Member

Masters Business Admin

ACORDA THERAPEUTICS, INC. Pharmaceuticals: Major

Enrique Carrazana

Jennifer Burstein

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Statistics

International

United States 48
Denmark 2
India 2
Canada 2

Sectoral

Health Technology 25
Consumer Services 16
Finance 5
Commercial Services 5
Retail Trade 2

Operational

Director/Board Member 608
Corporate Officer/Principal 273
Independent Dir/Board Member 183
Chairman 90
Undergraduate Degree 88
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW